Skip to main content
. 2016 Oct 12;7(52):85798–85812. doi: 10.18632/oncotarget.12622

Figure 3. Low Ki67/high ATM expression in malignant tumors predicts favorable DSOS in ES-HPBC (size < 4cm, LN < 4).

Figure 3

A subgroup of patients with tumor size < 4cm and LN < 4 were selected for further analysis. Kaplan-Meier analysis of DSOS between patients with high and low ATM expression alone A., high and low Ki67 expression alone B., and of patients in these four groups (low Ki67/high ATM, low Ki67/low ATM, high Ki67/high ATM, high Ki67/low ATM expression) C. C-index was used to evaluate the model prediction accuracy of single (ATM or Ki67) versus combined biomarkers (Ki67/ATM) D.